Healthcare -
Biotechnology - NASDAQ - US
$ 10.27
-2.38 %
$ 433 M
Market Cap
-3.4
P/E
URGN - FREE CASH FLOW
Free Cash Flow URGN - UroGen Pharma Ltd.
-76.6 M
LAST VALUE
5.45%
2 YEAR CAGR
-15.11%
5 YEAR CAGR
-40.18%
10 YEAR CAGR